Staging and treatment of oropharyngeal cancer in the human papillomavirus era

Head and Neck

Volumn 37, Issue 7, 2015, Pages 1002-1013

  Ward, Matthew J ^a   Mellows, Toby ^a   Harris, Scott ^b   Webb, Andrew ^c   Patel, Nimesh N ^c   Cox, Hugh J ^d   Piper, Kim ^e   Ottensmeier, Christian H ^a   Thomas, Gareth J ^a   King, Emma V ^a,d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

human papillomavirus (HPV); oropharyngeal cancer; TNM staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEEDING APPARATUS; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; MORTALITY; OROPHARYNX CANCER; PATIENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SWALLOWING; WART VIRUS; CARCINOMA, SQUAMOUS CELL; COMPLICATION; HEAD AND NECK NEOPLASMS; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROGNOSIS; VIROLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84931573454     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23697     Document Type: Article

References (33)

1. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 7th ed. New York: Springer-Verlag; 2010.
2. Adelstein DJ, Ridge JA, Gillison ML, et al., Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck 2009; 31: 1393-1422.
3. Office for National Statistics. General Lifestyle Survey 2009: Smoking and drinking among adults. New York, NY: Springer-Verlag; 2011.
4. Argiris A, Karamouzis MV, Raben D, Ferris RL,. Head and neck cancer. Lancet 2008; 371: 1695-1709.
5. Abendstein H, Nordgren M, Boysen M, et al., Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope 2005; 115: 2183-2192.
6. List MA, Siston A, Haraf D, et al., Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 1999; 17: 1020-1028.
7. Ang KK, Sturgis EM,. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin Radiat Oncol 2012; 22: 128-142.
8. Ang KK, Harris J, Wheeler R, et al., Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
9. Hong AM, Dobbins TA, Lee CS, et al., Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 2010; 103: 1510-1517.
10. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J,. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-1998.
11. Licitra L, Perrone F, Bossi P, et al., High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636.
12. Gillison ML, Zhang Q, Jordan R, et al., Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012; 30: 2102-2111.
13. Bishop JA, Westra WH,. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol 2011; 35: 1679-1684.
14. Robinson M, Sloan P, Shaw R,. Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 2010; 46: 492-496.
15. Granata R, Miceli R, Orlandi E, et al., Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study. Ann Oncol 2012; 23: 1832-1837.
16. Fischer CA, Kampmann M, Zlobec I, et al., p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 2010; 21: 1961-1966.
17. Sharma AK, Kies MS,. Pocket guide to TNM staging of head and neck cancer and neck dissection classification. In:, Deschler DG, Day T, editors. Alexandria, VA: American Academy of Otolaryngology-Head and Neck Surgery Foundation; 2008.
18. Hong AM, Martin A, Armstrong BK, et al., Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Ann Oncol 2013; 24: 215-219.
19. Fakhry C, Westra WH, Li S, et al., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-269.
20. Mendelsohn AH, Lai CK, Shintaku IP, et al., Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010; 120: 1788-1794.
21. Shoushtari AN, Meeneghan M, Treharne GC, et al., Clinical nodal staging of T1-2 tonsillar squamous cell carcinoma stratified by p16 status and implications for ipsilateral neck irradiation. Cancer J 2010; 16: 284-287.
22. Straetmans JM, Olthof N, Mooren JJ, de Jong J, Speel EJ, Kremer B,. Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 2009; 119: 1951-1957.
23. Goldenberg D, Begum S, Westra WH, et al., Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008; 30: 898-903.
24. Hafkamp HC, Manni JJ, Haesevoets A, et al., Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008; 122: 2656-2664.
25. Seethala RR,. Current state of neck dissection in the United States. Head Neck Pathol 2009; 3: 238-245.
26. Sedaghat AR, Zhang Z, Begum S, et al., Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 2009; 119: 1542-1549.
27. Klozar J, Kratochvil V, Salakova M, et al., HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 2008; 265 Suppl 1: S75-S82.
28. Fischer CA, Zlobec I, Green E, et al., Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer 2010; 126: 1256-1262.
29. Fulton-Lieuw T,. De-ESCALaTE HPV: determination of epidermal growth factor receptor-inhibitor (cetuximab) versus standard chemotherapy (cisplatin) early and late toxicity events in human papillomavirus-positive oropharyngeal squamous cell carcinoma: a randomised controlled trial. Warwick Clinical Trials Unit Division of Health Sciences Warwick Medical School; 2012.
30. Dysphagia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO), Raber-Durlacher JE, Brennan MT, et al., Swallowing dysfunction in cancer patients. Support Care Cancer 2012; 20: 433-443.
31. Rich JT, Liu J, Haughey BH,. Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer. Laryngoscope 2011; 121: 2381-2390.
32. Salassa JR,. A functional outcome swallowing scale for staging oropharyngeal dysphagia. Dig Dis 1999; 17: 230-234.
33. Moore EJ, Olsen SM, Laborde RR, et al., Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc 2012; 87: 219-225.